A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics
Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer-related deaths in the United States, and is projected to be second by 2025. It has the worst survival rate among all major cancers. Two pressing needs for extending life expectancy of affected individuals are the developmen...
Sparad:
Huvudupphovsmän: | , , , , , , , , , , , , , |
---|---|
Materialtyp: | Bok |
Publicerad: |
The Company of Biologists,
2015-10-01T00:00:00Z.
|
Ämnen: | |
Länkar: | Connect to this object online. |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Lägg till första kommentaren!